What ’s the Big Deal about Data in Medtech?
Discussion, âTop 5 Things You Need to Know about the Implantable Internet of Things." Brian Chapman, partner and leader of ZSâs medtech practice of ZS, attributes todayâs focus on data to the intersection of two important things: "A general recognition that understanding more and connecting actions with outcomes will provide feedback and understanding that will drive standards of care. This is not new, but as capabilities rise in data collection, aggregation, and synthesize rise, and coupled with machine learning, the promise of data in healthcare is becoming even more obvious. "Entrant of big, ostensibly âtechâplayers into healthcare has everyone realizing the potential. If you want to look for additional supporting trends, look no further than Googleâs proposed acquisition of FitBit, which is about both hardware and, possibly more importantly, access to an enormous trove of data. More proof in the news cycle recently is the visibility that just emerged about the relationship between Google and Ascension, which is all about data." Teresa Prego, senior vice president of marketing and business development, explained the connection between digital health and data during her keynote talk at MD&M Minneapolis. âHow do you even define digital health? [Itâs] taking technologies, information management, and advances in pul...
Authors: Sabet Sarvestani F, Azarpira N Abstract Heart and cerebral infarctions, as two important ischemic diseases, lead to the death of tissues due to inadequate blood supply and high mortality worldwide. These statuses are started via blockage of vessels and depletion of oxygen and nutrients which affected these areas. After reperfusion and restoration of oxygen supply, more severe injury was mediated by multifaceted cascades of inflammation and oxidative stress. microRNAs (miRNAs) as the regulator of biological and pathological pathways can adjust these conditions by interaction with their targets. Also, miRNAs...
CONCLUSIONS: Immunohistochemistry seems to be a promising option not only in clinical recognition, but also in the selection and monitoring of treatment effects. However, these methods have not yet recommended for routine clinical use. PMID: 33032462 [PubMed - as supplied by publisher]
Publication date: Available online 9 October 2020Source: NeuropsychologiaAuthor(s): Erin L. Meier, Shannon M. Sheppard, Emily B. Goldberg, Catherine R. Head, Delaney M. Ubellacker, Alexandra Walker, Argye E. Hillis
Publication date: Available online 9 October 2020Source: Neurología (English Edition)Author(s): J.P. Martínez-Barbero, P. Tomás-Muñoz, R. Martínez-Moreno
Authors: Kim JS, Hong SH, Kim WS PMID: 33029988 [PubMed]
Authors: Mantero V, Rigamonti A, Basilico P, Sangalli D, Scaccabarozzi C, Salmaggi A PMID: 33029982 [PubMed]
Authors: Kargiotis O, Safouris A, Psychogios K, Chondrogianni M, Andrikopoulou A, Theodorou A, Magoufis G, Stamboulis E, Tsivgoulis G PMID: 33029978 [PubMed]
CONCLUSIONS: In addition to bilateral HA, CNS infection alone was not a poor prognostic factor for the CNS infection-related epilepsy with HA group compared with the conventional MTLE with HA group. Based on these negative results, HA is a plausible and relevant lesion with similar clinical characteristics to HA in patients with conventional MTLE. Therefore, CNS infection-related MTLE with isolated HA might represent another subtype of MTLE with HA with a different etiology. PMID: 33029977 [PubMed]
CONCLUSIONS: The Korean MDS-UPDRS has the same overall structure as the English MDS-UPDRS. Our translated scale can be designated as the official Korean MDS-UPDRS. PMID: 33029970 [PubMed]
CONCLUSIONS: Young adult IS patients in Korea exhibit low awareness and poor management of their risk factors. Although the short-term outcome was relatively favorable in those patients, having SLE was associated with unfavorable outcomes. More attention needs to be paid for improving awareness and controlling risk factors in this population. PMID: 33029967 [PubMed]
More News: Cancer & Oncology | Cardiology | Clinical Trials | Conferences | Congestive Heart Failure | Economics | Economy | Education | Environmental Health | Epilepsy | Fish | Genetics | Health Management | Heart | Heart Attack | Heart Failure | Heart Transplant | Hospitals | Information Technology | Insurance | Insurers | Internet | Learning | Marketing | Medical Devices | Medicare | Mergers and Aquisitions | Orthopaedics | Parkinson's Disease | Partnerships | PET Scan | Physical Therapy | Politics | Science | Skin | Statistics | Stroke | Study | Universities & Medical Training